Who Paid My Doc
Nalmefene Hydrochloride
Drug Opioid Overdose
NDC 59011-960-10
General payments
$90,421
Research payments
$4,444,786
Through program year 2025, $90,421 in general payments and $4,444,786 in research payments were reported against Nalmefene Hydrochloride (Opioid Overdose).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $42,561 | 256 |
| 2025 | Research | $175,591 | 11 |
| 2024 | General | $30,899 | 276 |
| 2024 | Research | $681,615 | 8 |
| 2023 | General | $10,977 | 77 |
| 2023 | Research | $2,037,151 | 9 |
| 2022 | General | $5,985 | 27 |
| 2022 | Research | $1,550,429 | 8 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 27 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 29 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
636 general · 36 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.